[Clinical observation on electroacupuncture combined with acupoint injection for treatment of early postoperative inflammatory intestinal obstruction].
OBJECTIVE
To search for a better therapy for early postoperative inflammatory small bowel obstruction (EPISBO).


METHODS
Two hundred and forty cases were divided into four groups according to admitting order, 60 cases in each group. Routine treatments in western medicine were used in group A including gastrointestinal decompression, parenteral nutrition, anti-infection, supportive therapy and so on. Group B was treated with electroacupuncture in Zusanli (ST 36), Shangjuxu (ST 37) etc. in addition to those given in group A. Group C was treated with acupoint injection with Neostigmine in Dachangshu (BL 25), Zusanli (ST 36) etc. in addition to the treatment used in group A. Group D was treated with all of the treatments used in group A, B and C.


RESULTS
The total effective rate was 93. 3% in group A, 96. 7% in group B, 100.0% in group C and group D. There was no significant difference among the four groups (P>0. 05). The average recovery time of bowel sound was (11. 512. 9) days in group A, (9. 3 +/- 2.5) days in group B, (5.6 +/- 3.5) days in group C and (2. 2 +/- 1.7) days in group D. The average anal exsufflation time was (12. 5 +/- 3. 1) days in group A, (10. 7 +/- 3.6) days in group B, (7. 2 +/- 3. 1) days in group C and (2. 5 +/- 1. 5) days in group D. Group D was superior to those of other three groups obviously, and there were significant differences between them (all P<0. 01).


CONCLUSIONS
Electroacupuncture combined with acupoint injection has a satisfied therapeutic effect for treatment of EPISBO.
Shen
Li-ping
LP
Acupuncture Department, Subei People's Hospital of Jiangsu Province, Yangzhou 225001, China. w-xiaodong@hotmail.com
Guan
Juan
J
Ding
Kai-yun
KY
D015669:Acupuncture Points; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D015671:Electroacupuncture; D005260:Female; D006801:Humans; D007267:Injections; D007415:Intestinal Obstruction / Q000276:immunology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000008:administration & dosage*; D011183:Postoperative Complications / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D016896:Treatment Outcome
D009388:Neostigmine